So what do these new contenders mean for food and beverage
Some patients respond exceptionally well to GLP-1 monotherapy, while others may need the additional mechanisms of dual or triple agonists
Food stays in the stomach longer than usual
However, it is important to note that more research is necessary, and NAD therapy should be integrated into a broader treatment plan under medical supervision
(172) demonstrated in diabetic rat models that TMAO treatment exacerbated renal inflammation and fibrosis through activation of the NLRP3 inflammasome, promoting IL-1 and IL-18 release and increasing pro-fibrotic TGF-1 expression
PlexusDx integrates genetic insights into your full treatment plan, addressing not just GLP-1 sensitivity but also metabolic rate, hunger signaling, and nutrient utilization